stars 1 stars 2 stars 3

Periodyne is a brand of Imagenetix, Inc. (IAGX). Periodyne is a dental product that is used nightly as part of a patient's home care to decrease gingival inflammation and increase gingival health. Periodyne is formulated using a novel, patented and proprietary Cetylated Fatty Acid Complex (CFAC) that significantly reduces intercellular inflammation through the phospholipid enhancement of the cell membrane. CFAC has been shown to modulate systemic oral inflammation. Periodyne has been shown to significantly inhibit chronic oral tissue inflammation. Results of an inflammatory response clinical conducted at Boston University School of Medicine, Department of Periodontology, concluded that Periodyne significantly decreased inflammatory markers contributing to the pathogenesis of periodontal health. Clinical trials show that Periodyne begins to significantly reduce both periodontal pocket depths and bleeding on probing (BOP) in just 2 weeks (West Coast University). There are no known adverse side effects associated with Periodyne. Periodyne is applied in just seconds a day at home after brushing and can be used once at bedtime or more often as recommended by the dental professional.

Website http://www.periodyne.com
Revenue $3 million
Employees View employees
Founded 2014
Industry Pharmaceutical Manufacturing
Competitors Zymergen, Inc., Synthace, Geno, Arzeda, Novozymes, LanzaTech, Amgen, Synthesio, Cellectis +36 more (view full list)

Periodyne Questions

The Periodyne annual revenue was $3 million in 2026.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users